In this study, we verified the treatment planning calculations of skin doses with the incorporation of the bolus effect due to the intervening alpha-cradle (AC) and carbon fiber couch (CFC) using radiochromic EBT2 films. A polystyrene phantom (25 3 25 3 15 cm 3 ) with six EBT2 films separated by polystyrene slabs, at depths of 0, 0.1, 0.2, 0.5, 1, 1.4 cm, was positioned above an AC, which was 1 cm thick. The phantom and AC assembly were CT scanned and the CT-images were transferred to the treatment planning system (TPS) for calculations in three scenarios: (A) ignoring AC and CFC, (B) accounting for AC only, (C) accounting for both AC and CFC. A single posterior 10 3 10 cm 2 field, a pair of posterior-oblique 10 3 10 cm 2 fields, and a posterior IMRT field (6 MV photons from a Varian Trilogy linac) were planned.
Introduction
There are growing concerns about the degradation of skin sparing (also called bolus effect) when radiation beams are delivered through immobilization/support devices (ISD) and/or couches that are in contact with skin (1-4). Such concern is further elevated when single-fraction or hypofractionated treatment with IMRT and overlapping stereotactic fields are delivered. Since the carbon fiber couch (CFC) has become an integrated part of linear accelerators for image guided radiation therapy (IGRT), it is crucial that the treatment planning system (TPS) calculations account for beam attenuation and bolus effect of any intervening ISD and CFC.
For photon beams delivered through the CFC and ISD with variable thicknesses, such as carbon fiber grid with Mylar sheet, stretched perforate AquaPlast TM , alpha-cradle (AC), or vacuum immobilization devices, there have been reports of dose attenuation beyond d max and dose enhancement in skin layers based on the dose measurement using thimble or parallel plate ion chamber (4-22), TLD (3, (23) (24) (25) , OSLD (3, 25) , radiochromic film (24, (26) (27) (28) , radiographic film (20), EPID (29), and Monte Carlo modeling (30). The conventional skin dose measurements using TLD (23) (24) (25) (31) (32) (33) , diode (34, 35) , MOSFET (31, 32, 36) , and OSLD (37, 38) detectors are limited to discrete points on the skin surface. For the support devices with variable thicknesses, studies on the two-dimensional (2D) variation of the dose perturbation using 2D dosimeters for both conventional and IMRT fields have been reported (27, 29, 39) . Vieira et al. studied the beam attenuation due to treatment couch and ISD using 2D EPID images and found up to 15% attenuation for treatments of head and neck cancer patients with a 6 MV photon beam (29) . Chiu-Tsao and Chan reported on the evaluation of 2D bolus effect of ISD on skin doses for 10 3 10 cm 2 flat field and IMRT field using radiochromic EBT film dosimetry. They observed that enhancement in skin doses varied with the local thickness of an ISD and the size of the area of interest, and could be up to a factor of 4 at the depth of 0.0153 cm (27) .
Radiochromic EBT film has been established as an accurate quantitative 2D dosimeter with fine spatial resolution for applications in external beam and brachytherapy, including IMRT QA, commissioning of treatment modalities and verification of TPS . In particular, due to its weak energy dependence (41) (42) (43) (44) (45) , thin configuration (0.024 cm thick), and tissue equivalency (Zeff 5 6.98) (40), EBT film has been demonstrated as a useful tool for measuring 2D skin dose variations at the air interface and the buildup region for brachytherapy, conventional and IMRT external beam modalities (46-50, 54, 55) . In addition, EBT film has adequate sensitivity in the dose range of clinical radiation therapy (50-53), hence it would be a viable in vivo dosimeter in the primary beams. The recently introduced radiochromic film, EBT2, a successor of EBT film, has dosimetric characteristics that are similar including its weak energy dependency (45, (63) (64) (65) (66) . The use of EBT2 film for IMRT QA and verification of calculated 2D dose distributions has also been reported (67-69).
Despite numerous published reports on the magnitude of the bolus effect on skin doses due to the intervening ISD and CFC, many current treatment plans still do not incorporate ISD and CFC into calculations, thus resulting in significant underestimate of skin doses from TPS calculations. It is crucial to predict the accurate skin doses before a treatment starts, particularly for single fraction or hypofractionated treatments. The ultimate solution to the accurate determination of the skin doses (at depths from 0 to 0.5 cm) must be from accurate treatment planning calculations, which take into account the intervening materials, like ISD and CFC. To assure such accuracy, the TPS dose calculation accounting for the intervening ISD and CFC should be verified by measurements using appropriate dosimeters. In recent years, there have been several reports on the investigations to accurately incorporate the dose perturbation effects of the intervening CFC in commercial TPSs. All of the studies mentioned above were about the effect of CFC alone. To immobilize patients during a treatment, a customized alpha-cradle or other ISD is also frequently used to provide support and is in contact with the patient's skin surface. To the best of our knowledge, no one has studied the accuracy of TPS in determining the bolus effect in 2D on the skin layers from zero to d max due to the combination of AC and CFC using EBT2 film dosimetry. In this paper, we focus our investigation on doses in skin layers due to the combined bolus effect of the AC and CFC. We performed dose calculations in a polystyrene phantom using an inhouse TPS for conventional and IMRT radiation fields with normal and oblique incidence in three different scenarios: (A) ignoring all intervening support devices, (B) accounting for intervening AC only (C) accounting for intervening AC and CFC. The dose distributions for these three scenarios were compared, with particular emphasis on the doses in skin layers in terms of bolus effect. In addition, the verification of the accuracy of the TPS calculated skin-layer doses accounting for the bolus effect due to intervening AC and CFC was performed using 2D dosimetry with radiochromic EBT2 films embedded in a polystyrene phantom.
Materials and Methods

Modeling of IGRT Couch in TP
Varian Exact® IGRT couch, made of carbon fiber, is designed to facilitate radiographic, fluoroscopic, and cone-beam CT (CBCT) guided therapies. To model the couch in our TPS, CBCT was used to obtain external contours of the couch. These images were inserted into patient contours module and were used when treatment beams passed through the IGRT couch. It is important to know the index of couch related to the patient's isocenter due to the non-uniform thickness along longitudinal direction. The contour of couch associated with each CT image would reflect the actual thickness of the couch on that particular CT slice. In TPS a relative electron density of 0.11 (with respect to water) was assigned to the couch to calculate the effective transmission, which matches our couch attenuation measurements by ion-chamber. The measurements were taken at two different longitudinal positions of the couch with the beam pointing upward and going through the couch. The ratio of measured data with and without the couch was the transmission coefficient for the associated couch thickness. For example, the average transmission coefficient for 6 MV photon beams is 0.977. Also, in the CT images the relative pixel values (grayscale) of AC with respect to water ranged from 0.07 to 0.1 depending on the deposition of the materials across the cradle. Furthermore, the water-equivalent-thickness (WET) for AC and the combined AC 1 CFC are estimated about 0.2 cm and 0.7 cm, respectively, for the 6 MV beam going through the materials.
Treatment Planning Calculations
A polystyrene phantom (25 3 25 3 15 cm 3 ) with six EBT2 films from the same lot (#A09031001A), (International Specialty products, Wayne, NJ) separated by polystyrene slabs, at depths of 0, 0.1, 0.2, 0.5, 1.0, and 1.4 cm, was positioned on an AC, which was 1 cm thick. This phantom and AC assembly were scanned using a Phillips Big Bore CT scanner and the CT images (120 kVp, 400 mAs, 3 mm slice thickness) were transferred to the Memorial Sloan-Kettering Cancer Center planning system (73-75), which is capable to incorporate the Varian IGRT couch into any patient plan, for calculations in three scenarios: (A) ignoring AC and CFC, (B) accounting for AC only, (C) accounting for both AC and CFC. Three different radiation field configurations of 6 MV beams from a Varian Trilogy were planned separately in the TPS, namely, (1) a single posterior field, ( as exterior heterogeneities for use in the dose calculations. The window level does not matter as long as it is adjusted so that the AC external outline is clearly visible. The couch was inserted in the TPS using the pre-modeling contours.
For each radiation field configuration, a treatment plan was developed and the same MU were used for all three planning scenarios. Isodose curve displays were generated and central axis doses were calculated at depths of 0, 0.1, 0.2, 0.5, 1, 1.4 cm and isocenter (depth of 4.7 cm). For the single posterior 10 3 10 cm 2 field, gantry 5 1808 (IEC scale), 384 MU were used so that the dose at the isocenter would be 350 cGy in scenario A. For the pair of posterior-oblique 10 3 10 cm 2 fields, gantry 5 1508 and 2108 (IEC scale), 197 MU were used for each field so that the total isocenter dose (from both fields) would be 350 cGy in scenario A. For the posterior IMRT field at gantry 5 1808 (IEC scale) in a dynamic MLC mode, 396 MU were used to deliver 125 cGy (lower isocenter dose due to the large dose variation in the IMRT field) to the same isocenter in scenario A.
Irradiation of EBT2 Films in Polystyrene Phantom
For each radiation field configuration, a separate set of six EBT2 films were positioned at the depths of 0, 0.1, 0.2, 0.5, 1 and 1.4 cm in the polystyrene phantom. Micropore tape (3M) was used to secure the film edges on the polystyrene phantom to minimize air gaps between film layers and phantom slabs. The entire phantom assembly was positioned above the AC and CFC for radiation "treatment" based on the treatment plan in scenario C developed for this configuration. All beams were delivered through the AC and CFC (Figures 1-3 ). In addition, a film was exposed at 0.2 cm depth in polystyrene phantom by the anterior IMRT field from above (gantry 5 08) in the absence of the AC and CFC. In order to quantify the 2D bolus effect, the measured dose values extracted from this film were compared with those from the film at 0.2 cm depth irradiated by the posterior IMRT beam through the intervening AC and CFC.
In vivo Measurement of a Lung IMRT Patient
A lung stereotactic body radiation therapy (SBRT) patient was planned using 4 IMRT 6 MV beams in a dynamic MLC mode. Two of the fields entered posteriorly through the Varian IGRT couch and AC to reach the patient. The plan was designed to deliver a fraction of 900 cGy to the isocenter inside the target volume of the patient. Figures 4A-C show the axial images of the treatment plans with the 3 planning scenarios for the IMRT lung patient. Since it is not a phantom measurement, the only measurable depth is the surface of the patient's skin (d 5 0). In the patient's IMRT plan, a calculation point located at the hot spot on the skin in contact with the AC was created for comparison purpose. The hot spot doses were 314, 371, 530 cGy for scenarios A, B, and C, respectively. A piece of EBT2 film in size of 6 3 6 cm 2 was taped on the patient's skin before setting up the patient on the alpha-cradle. The film was centered at on the TP predicted hot spot location on the patient's skin. The 2D dosimetry comparison was performed using our in-house film analysis software.
Irradiation of Calibration Films
The EBT2 calibration films each in a size of 5 3 5 cm 2 were irradiated by 6 MV photon beams of a Varian Trilogy linac at the center of 10 3 10 cm 2 field. The films were irradiated at d max (1.4 cm) and 100 cm SAD in a water-equivalent solid phantom (25 3 25 3 20 cm 3 ). Calibration film doses were calibrated against the ion chamber (Standard Imaging Exradin A-12 0.65 cc thimble chamber with ADCL calibration) measurement at the same location and depth. The output of the Trilogy linac was calibrated per AAPM TG-51 protocol. With the MU settings from 0 through 500 MU, the doses to the calibration films ranged from 0 through 500 cGy.
Scanning of Films
All measured EBT2 films, calibration and background films were scanned at the same central location and orientation on an Epson 10000XL flatbed scanner in transmission mode. The polymer emulsion coating direction of the film was parallel to the scanning direction on the scanner bed. The settings of 48 bit color and 72 dpi (0.035 cm per pixel) were used, color correction was disabled, and files were saved in TIFF format. The calibration films, background films, and experimental films were scanned one at a time at least 16 hours after irradiation.
Data Processing and Analysis
The red channel data were extracted using a software, ImageJ (76) For each calibration or background film, the average of the pixel values in an area of about 1 3 1 cm 2 at the film center was calculated and assigned as the PV of the film. PV background is the PV of the background film.
The NOD values of the calibration films were plotted against dose values (in cGy) to form the calibration curve. The calibration curve was fitted by a third order polynomial. Conversion from net optical density readings to doses was achieved based on the polynomial fit to the calibration curve.
Results
Treatment Planning Calculation Results
The isodose line plots in the sagittal plane generated from the treatment plan for a single posterior field are shown in Figure 1 in three planning scenarios: A: ignoring AC and CFC, B: accounting for AC only, and C: accounting for both AC and CFC. The isodose curve plots in an axial plane generated from the treatment plan for a pair of posterior-oblique fields are shown in Figure 2 , also for three planning scenarios. The dose attenuation beyond d max by the AC and CFC can be observed by the slight change of the isodose line of 350 cGy. The dose enhancement in the superficial region can be seen as the isodose line of 400 cGy moving closer to the surface from A to B to C. The isodose curve plots in a coronal plane at depth of 0.5 cm for the posterior IMRT field are shown in Figure 3 for three planning scenarios.
The central axis dose values at the depths of 0, 0.1, 0.2, 0.5, 1.0, 1.4 and 4.7 cm (isocenter) generated from the treatment plans are listed in Table I for each radiation field configuration and in planning scenarios A, B and C for comparison. We can see the drastic difference among the scenarios A, B and C. In addition, by extracting the calculated depth doses in Figure 1 or the "posterior field" data from Table I, Figure 5 depicts the percent depth dose as a function of WET shifted depth for the three scenarios overlaying with the measured EBT2 film data. The WET shifted depth is the WET 1 physical depth. As can be seen, the WET (0.2 cm for AC and 0.7 cm for AC 1 CFC) could be a potential predictor for dose change from the bolus effect of intervening materials.
Calibration Curves
The NOD values of the calibrated EBT films of lots #A09031001A were plotted against dose values, as shown in Figure 6 . A 3 rd order polynomial was obtained for dose conversion from NOD values, as shown in Eq.
[2]. D (cGy) 5 c 0 1 c 1 NOD 1 c 2 NOD 2 1 c 3 NOD 3 [2] where the coefficients are c 0 5 0.29005, c 1 5 671.03, c 2 5 1404.4, c 3 5 2214.
Dose Comparison of EBT2 Film Measurements and TPS Data for 10 3 10 cm 2 Fields
Point doses and planar distributions generated from the TPS for the three scenarios were compared with the measurement Table I Comparison of measured dose values of EBT2 films and those calculated in TPS at various depths for three TP scenarios. The percent difference (%Diff) is calculated as: 100% 3 (TP-EBT2)/EBT2. For the posterior 10 3 10 cm 2 filed and IMRT field, the points are along the central axis. For the pair of oblique 10 3 10 cm 2 fields, the points are along the central vertical line passing through the isocenter. data. Table I shows the dose comparison at the central points of EBT2 film measured data with the TPS values for three scenarios at the depths of 0, 0.1, 0.2, 0.5, 1.0, and 1.4 cm. The EBT2 film data agree with the doses calculated by our TPS for scenario C, within the uncertainty of the EBT2 measurements (,4%). For the posterior 10 3 10 cm 2 field, the TPS generated central axis doses were lower than the EBT2 measurements by 34%, 33%, 31%, 13% for scenario A and by 27%, 24%, 22%, 8% for scenario B at the depths of 0, 0.1, 0.2, 0.5 cm, respectively. For the pair of posterior-oblique fields, the TPS generated doses along the central vertical line were lower than the EBT2 measurements by 34%, 31%, 31%, 11% for scenario A and by 25%, 21%, 21%, 6% for scenario B at the depths of 0, 0.1, 0.2, 0.5 cm, respectively. There were no significant differences at the depths of 1.0 and 1.4 cm. For the IMRT lung patient's in vivo study, the measured hot spot on the EBT2 film was 508 cGy , as compared to the TPS data of 314, 371, 530 cGy for scenario A, B, and C, respectively. This shows the measured skin dose was in the close proximity (4%) of the TPS calculation in scenario C. Based on the above in vitro and in vivo measurement results, the conventional TPS dose calculations (without taking into account external heterogeneity) significantly underestimate the skin doses if the skin is in contact with AC and CFC.
IMRT Field and 2D Dose Distributions
For the IMRT field, the point doses and 2D dose distributions at each depth calculated in scenario C agree with those measured data. When comparing the central axis doses for the IMRT field, we found the TPS generated doses for scenario A (B) were lower than the EBT2 measurements by 35%, 34%, 31% 16% (29%, 26%, 23%, 10%) at the depths of 0, 0.1, 0.2, 0.5 cm, respectively. There were no significant differences for the depths of 1 and 1.4 cm. (See Table I ). The results of the quantitative EBT2 film dosimetry analysis for the IMRT field at depth of 0.2 cm with and without AC and CFC are shown in the 2D color-wash isodose displays in Figures 7(A) and (B) , respectively. We observe much higher doses with (b) compared with those with (a), indicating major dose enhancement (bolus effect) due to combined AC and CFC. The overlay of isodose plots at depth of 0.2 cm from EBT2 film data and generated from TPS accounting for the bolus effect of AC and CFC are shown in Figure 8 . The isodose distributions from EBT2 and TPS agree with each other. Gamma analysis was performed, yielding the gamma score of 96% passing rate for 3%/3 mm criteria. The agreement between the 2D doses from TPS and EBT2 is also observed for the other depths. Thus, the TPS calculated 2D doses with the bolus effect of AC and CFC are verified by the EBT2 film measurements.
Discussion
The depths of 0, 0.1, 0.2, 0.5, 1.0, and 1.4 cm mentioned for the EBT2 films in the polystyrene phantom were the nominal depths. Since the EBT2 film thickness is 0.028 cm, the total thickness of all six-film layers would be 0.168 cm. The effective measurement depths would be shifted from the nominal depths slightly. The actual depth of each film layer was identified in the CT images and used in the TPS dose calculation. Hence, the TPS calculated dose values tabulated in Table I and isodose curve displays in Figure 7 are for the actual depths of the EBT2 films.
The EBT2 films used in the CT scanning for TPS calculations were "dummy" films. For each radiation field configuration, separate set of films from the same lot was exposed.
The uncertainties of the measured doses were estimated following the method described in the EBT film studies (27, 50) . Combining the Type A (random, statistical) and Type B (non-random, systematic) uncertainties, the uncertainties of the measured doses at individual pixels were about 4%.
The calculated superficial doses for open fields from many conventional TPSs are overestimates of the actual doses (49, 50, 72) . At the time of commissioning a TPS, it is common to use thimble ion chamber or diode to gather data of percent depth doses and beam profiles in water phantom for data entry into the TPS. Due to the inherent buildup materials and chamber geometry of these detectors, the measured doses at the superficial buildup region were higher than those from extrapolation and thin window parallel plate ion chambers.
With the entry of the higher (than actual) dose data in the superficial buildup region into the TPS, the TPS calculated doses in this region might be higher than the actual doses. Such issue of overestimate of superficial doses for open fields by conventional TPS has been recognized, but was considered difficult to address in conventional TPS algorithm and also accepted as a conservative approach in clinical practices.
Despite the uncertainty of skin doses by TPS for open fields, our EBT2 measurements showed that the skin doses are accurately predicted by the scenario with the external heterogeneities (AC and CFC) accounted for.
Even if the TPS predicted dose of 246 cGy at d 5 0 for planning scenario A were accepted as a reference for open field, the dose of 389 cGy at d 5 0 for planning scenario C is greater by a factor of 1.6. That indicates that the TPS calculated doses with the bolus effect of AC/CFC ignored could be underestimate of the actual skin doses by about 35% (Table I) .
Similar percentage applies to the pair of oblique fields and normal IMRT fields. At depth of 0.5 cm, the TPS predicted dose values are expected to be accurate for open fields. We note in Table I that the dose in planning scenario C is larger than that in scenario A by about 10% plus. For example, the 30% isodose line in Figure 3A was actually the 50% isodose line in the TPS extended to the shallow depth near the surface in the presence of the AC and the IGRT couch ( Figure 3C ). That means, the 30% isodose line near the skin surface from the TPS calculation (ignoring the AC and CFC) should really be about 50% if the presence of AC/CFC materials were taken into account correctly in the TPS. In clinical practice, when multiple beam orientations are employed and only a few of the beams pass through the AC and CFC, the overall effect on the clinical dose distribution may be minimal. However, this study raises awareness of clinical importance of proper dose calculations, especially when planning for single or hypofractionated treatments (i.e., spine tumors) where most beams are coming through posteriorly. Pan et al. (3) and Fontenla et al. (25) used TLD and OSLD to measure doses in vivo for patient cases with AC/CFC and compared the point dose measured with the TPS values. The in vivo dosimetry showed patient surface dose could be 50% higher than that calculated by the TPS, but their data are limited to doses at discrete points. They suggested that to limit skin toxicity for SBRT one must consider the skin dose due to immobilization devices, beam placement, and energy selection. Most published reports were on the attenuation and bolus effect due to patient's ISD or CFC. To our knowledge, this is the first report on the comparison of the 2D measurement data with the TPS taking into account both the intervening AC and CFC.
Since the megavoltage doses vary with depths steeply in shallow layers, it is important to achieve precise dose measurements and compare with the calculated values from TPS. The depths of sensitive skin layers vary with the part of the body and with patient. The ICRU issued guideline of skin depth as 0.007 cm (70 microns) depth for purposes of radiation protection (77). Archambeau et al. studied dose response of gross and histologic changes linked to the acute and late changes of the skin based on a composite pathophysiologic operational model and reported that a skin functional unit consisted of a microvessel with associated epidermis and dermis. The epidermal shell is 0.003-0.03 cm (30-300 microns) and dermis is 0.1-0.3 cm thick (78). The RTOG 0915 defined the skin as the outer 0.5 cm of the body surface (79). As such it is a rind of uniform thickness (0.5 cm) which envelopes the entire body in the axial planes. It is not possible to measure in vivo within this depth in a patient; therefore, it's the user's responsibility to calculate the dose at this depth accurately with TPS. The skin as a volume structure in DVH has max, mean, and min doses. We observe that the max dose is located at the depth of 0.5-cm for the pre-defined skin volume. We agree that, from the physics point of view, the skin dose reaches its maximum at 0.5 cm depth, with or without the presence of the immobilization device in this study.
Although the RTOG requires calculation of the skin as a rind of 0.5 cm, it is still relevant to know the surface area covered by the hot spot identified using film. This work has validated the TPS dose calculation algorithm accounting for the most common immobilization device and IGRT couch. The given method should be applicable to any other TPS and other patient supporting devices. The actual AC custom-made for a patient would have variable thicknesses and curvatures. In this study, we examined an AC with a nominal thickness of 1 cm placed above the top section of a Varian Trilogy CFC. This method could be generalized to other ISD of different thicknesses and other sections of the CFC, for head and neck, lung, and pelvis treatments.
However, the challenge is in the clinical effect. While there is some uncertainty and variation in the depth range for reaction, one can infer the affected depth to be within a few millimeters near the skin surface. The dose at 0.5 cm depth is usually not low for the conventional and IMRT Treatment modalities with 6 MV. With the presence of the support devices, the dose at 0.5 cm depth does increase, but by smaller percentage as compared to the dose increases at shallower depths. For example, the doses at 0, 0.1 and 0.2 cm depths increase by a large percentage, in the presence of immobilization devices. Hence, it is reasonable to assume that the observed skin reaction is related to the higher dose in the layers shallower than 0.5 cm depth. To answer such question, it will require a largescale clinical study.
Conclusions
TPS calculation of doses in the buildup region, accounting for AC and IGRT couch top, was verified by EBT2 film measurements. Ignoring the presence of AC and/or CFC in TPS calculation would significantly underestimate the doses in the buildup region. The effect is more pronounced at shallower depth. The solution to the determination of the skin doses is accurate TPS calculations, which correctly take into account the intervening heterogeneity of immobilization/ support devices. For the clinicians, as more hypofractionated regimens and stereotactic regimens are being used, this information will be useful to avoid potential serious skin toxicities, and also assist in clinical decisions and report these doses accurately to relevant clinical trials/cooperative groups, such as RTOG.
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